Want to see HK:0673 full AI Analyst Report?
0673 Stock Chart & Stats
HK$0.30
HK$0.03(9.09%)
At close: 4:00 PM EST
HK$0.30
HK$0.03(9.09%)
Day’s Range― - ―
52-Week RangeHK$0.25 - HK$0.86
Previous CloseN/A
Volume864.00K
Average Volume (3M)75.88K
Market Cap
HK$430.01M
Enterprise ValueHK$711.52
Total Cash (Recent Filing)HK$21.95M
Total Debt (Recent Filing)HK$4.59M
Price to Earnings (P/E)―
Beta0.12
Next Earnings
Nov 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding1,387,138,200
10 Day Avg. Volume37,390
30 Day Avg. Volume75,875
Financial Highlights & Ratios
PEG Ratio0.16
Price to Book (P/B)9.44
Price to Sales (P/S)12.24
P/FCF Ratio-5.83
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
2026 Revenue ReboundThe sharp 2026 revenue rebound shows that the business can still recover sales after a period of contraction. If sustained, renewed volume would improve operating leverage, broaden the revenue base, and provide a foundation for rebuilding profitability over the next several quarters.
Modest Leverage When Equity Is PositiveRelatively modest leverage in periods with positive equity limits the direct burden of debt on the business and reduces near-term balance-sheet stress. This provides some financial flexibility compared with a highly levered distributor, although the benefit depends on restoring a sound equity base.
Losses Narrowed In 2026The reduction in losses during 2026 is an early indication that performance may be moving in a less adverse direction after the prior deterioration. A continuing improvement could reduce the pace of capital erosion, strengthen financial resilience, and support eventual operating recovery.
Bears Say
Persistent Losses And Deeply Negative MarginsRecurring losses and extremely negative margins indicate that the current revenue base is not covering the company’s cost structure. This weak earnings profile limits internal funding, erodes capital over time, and makes a durable recovery dependent on substantial operating improvement.
Severe Cash BurnSustained negative operating and free cash flow shows that the business is not self-funding its operations. The very large 2026 outflow increases reliance on financing or balance-sheet support, constrains investment capacity, and raises the risk that growth cannot be maintained without additional capital.
Negative Equity And Shrinking Asset BaseNegative equity reflects accumulated financial deterioration and leaves less balance-sheet protection for creditors and shareholders. The simultaneous decline in total assets suggests a shrinking operating footprint, reducing the resources available to absorb losses or support a sustained recovery.
China Health Group News
0673 FAQ
What was China Health Group Ltd’s price range in the past 12 months?
China Health Group Ltd lowest stock price was HK$0.25 and its highest was HK$0.86 in the past 12 months.
What is China Health Group Ltd’s market cap?
China Health Group Ltd’s market cap is HK$430.01M.
When is China Health Group Ltd’s upcoming earnings report date?
China Health Group Ltd’s upcoming earnings report date is Nov 27, 2026 which is in 69 days.
How were China Health Group Ltd’s earnings last quarter?
China Health Group Ltd released its earnings results on Jun 30, 2026. The company reported -HK$0.027 earnings per share for the quarter.
Is China Health Group Ltd overvalued?
According to Wall Street analysts China Health Group Ltd’s price is currently Overvalued.
Does China Health Group Ltd pay dividends?
China Health Group Ltd does not currently pay dividends.
What is China Health Group Ltd’s EPS estimate?
China Health Group Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does China Health Group Ltd have?
China Health Group Ltd has 1,387,138,200 shares outstanding.
What happened to China Health Group Ltd’s price movement after its last earnings report?
China Health Group Ltd reported an EPS of -HK$0.027 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of China Health Group Ltd?
Currently, no hedge funds are holding shares in HK:0673
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
China Health Group Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-27.90%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
6.93%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
China Health Group Ltd
Serving as an investment holding company, China Health Group Limited engages in a diverse range of operations. Within the People's Republic of China, its core business involves the supply and maintenance of medical equipment and disposables, coupled with the administration and operation of healthcare facilities. The company also extends its activities into commercial factoring and real estate investment. Previously operating under the name China HealthCare Holdings Limited, the company officially adopted "China Health Group Limited" in September 2015. Its principal office is located in Central, Hong Kong.
Technical Analysis
Shanghai Pharmaceuticals Holding Co
―
Sinopharm Group Co
―
IVD Medical Holding Limited
―
Medlive Technology Co., Ltd.
―
Charmacy Pharmaceutical Co., Ltd. Class H
―